Vomaris Innovations, Inc. specializes in bioelectric technology that has the potential to revolutionize infection control and wound healing. The company name is derived from nature’s remarkable ability to generate electricity when voltage potential (Vo) combines with a conductive medium like saline (mar, meaning the ‘sea’ in Spanish). This is the foundational principle of Vomaris’s patented V.Dox™ Technology, which is defining the bioelectric wound care market.
Bioelectric technology from Vomaris is the only platform in the world that powers a new generation antimicrobial dressing for the wound and incisional care markets.
Vomaris’s mission is to revolutionize wound healing and infection control through the delivery of microcell battery-powered electricity.
President & CEO
- Michael Nagel joined Vomaris Innovations as President and CEO in February 2012.
- Mr. Nagel brings more than 30 years of sales and marketing experience in the medical device industry.
- Prior to Vomaris, Mr. Nagel served as Chief Commercial Officer at Neomend. He oversaw the commercial launch of a PMA device and guided rapid growth to over 1,200 hospitals. Neomend was acquired by C.R. Bard.
- Mr. Nagel also served as Co–Founder and Vice President of Worldwide Sales and Marketing at Vascular Solutions (VASC). He helped take Vascular Solutions from inception to IPO within 39 months and led the launch of a novel, biological vascular closure device in the interventional marketplace.
- He also served as Vice President of Sales and Marketing at Incisive Surgical.
- Mr. Nagel holds an MBA and BA from the University of St. Thomas.
Chief Commercial Officer
- Mary Maijer joined Vomaris Innovations as Chief Commercial Officer in May 2014.
- Ms. Maijer brings over 30 years experience in health care, global medical device marketing, and marketing operations.
- Prior to Vomaris, Ms. Maijer served as Vice President of Marketing at Covidien where she was responsible for the Peripheral Vascular business.
- Prior to Covidien, Ms. Maijer spent several years at St. Jude Medical where her most recent roles were as Vice President of Global Marketing Operations and previously as Vice President of International Marketing for CRMD, AF, and CV Divisions.
- She has extensive experience in strategic portfolio planning, upstream and downstream marketing, leadership and business development, and has launched a multitude of new technologies into the marketplace with global commercial success.
- Ms. Maijer holds a BA from the College of St. Scholastica.
Chief Financial Officer
- Michel Tanguay joined Vomaris Innovations in April 2014 and is currently responsible for the company’s finance, information technology, and operations functions.
- Prior to joining Vomaris, Mr. Tanguay headed the Finance and Purchasing functions for a start-up company manufacturing steel components for the solar industry.
- He previously served in a number of senior level finance positions with public companies in the US and Canada including Abitibi Consolidated and Bombardier.
- Mr. Tanguay also directed the Finance and Contract Administration organization for the All Americas Division of Diagnostica Stago, a manufacturer of in vitro diagnostic instruments and reagents.
- His career started with Ernst & Young in Montréal, Canada.
- Mr. Tanguay is a Certified Public Accountant (inactive, Illinois), a Chartered Professional Accountant (Québec, Canada), and holds a bachelor’s degree in accounting from the Université du Québec à Montréal.
AwardsView All Awards
Partner With Vomaris
Based on firmly established principles of the essential role electricity plays in regeneration and healing, V.Dox Technology has utility across a broad-spectrum of applications. Become a partner in advancing microcell battery-generated electricity to power the future of wound healing and infection control.Become a Partner